Cardinal Health (CAH)
(Delayed Data from NYSE)
$94.16 USD
-0.30 (-0.32%)
Updated Jul 12, 2024 03:59 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Cardinal Health (CAH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$112.93 | $130.00 | $94.00 | 20.01% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Cardinal Health comes to $112.93. The forecasts range from a low of $94.00 to a high of $130.00. The average price target represents an increase of 20.01% from the last closing price of $94.10.
Analyst Price Targets (14)
Broker Rating
Cardinal Health currently has an average brokerage recommendation (ABR) of 2.37 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 2.37 a month ago based on 15 recommendations.
Of the 15 recommendations deriving the current ABR, five are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 33.33% and 6.67% of all recommendations. A month ago, Strong Buy made up 33.33%, while Buy represented 6.67%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/CAH.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 8 | 8 | 8 | 8 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.37 | 2.37 | 2.37 | 2.37 | 2.37 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/18/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Hold | Hold |
6/12/2024 | SVB Securities | Michael Cherny | Strong Buy | Strong Buy |
5/15/2024 | Argus Research Corp. | Kristina Ruggeri | Strong Buy | Strong Buy |
5/3/2024 | Robert W. Baird & Co. | Eric W Coldwell | Strong Buy | Strong Buy |
5/3/2024 | Evercore Partners | Elizabeth Anderson | Hold | Hold |
4/29/2024 | Wells Fargo Securities | Stephen Baxter | Strong Sell | Strong Sell |
4/1/2024 | Cowen & Co. | Charles Rhyee | Hold | Hold |
2/1/2024 | Not Identified | Not Identified | Hold | Hold |
1/29/2024 | UBS | Kevin Caliendo | Strong Buy | Strong Buy |
1/3/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.37 |
ABR (Last week) | 2.37 |
# of Recs in ABR | 15 |
Average Target Price | $112.93 |
LT Growth Rate | 12.00% |
Industry | Medical - Dental Supplies |
Industry Rank by ABR | 77 of 252 |
Current Quarter EPS Est: | 1.72 |